Carcinogenesis, Vol 18, 911-917, Copyright © 1997 by Oxford University Press
R Fasciati and P Maier
Down-regulation of the mitogenic activity of the rodent liver carcinogen
cyproterone acetate (CPA) and of epidermal growth factor (EGF) were
compared in cultured rat hepatocytes. Both hepatomitogens produce an
increase in the expression of proliferating cell nuclear antigen (PCNA) and
in [3H]thymidine incorporation in a dose-dependent manner. In combination,
the two mitogens induced an additive mitogenic response. Concomitant
exposure to the growth inhibitory cytokine transforming growth factor beta1
(TGF-beta1) resulted in a differential dose-dependent down-regulation of
PCNA-expressing cells. The corresponding down-regulation of CPA-induced
PCNA expression required a 3- to 5-fold higher TGF-beta1 concentration than
for EGF-induced expression. In contrast, CPA-exposed hepatocytes become
vulnerable to and EGF-exposed cells protected against the
apoptosis-inducing activity of TGF-beta1 (>0.1 ng/ml). Under culture
conditions that mimicked a pericentral-equivalent microenvironment (low
oxygen tension, low glucagon concentration), PCNA expression was 3-fold
lower and CPA- specific resistance was no longer detectable. It is
concluded that EGF and CPA induce their growth stimuli preferentially in
the periportal area of the liver but in different hepatocyte
sub-populations, which differ in their down-regulation of premitotic events
by TGF-beta1. At low TGF-beta1 concentrations, EGF-stimulated cells shift
back into a resting cell cycle phase, whereas CPA-treated hepatocytes are
eliminated by apoptosis at higher TGF-beta1 concentrations.
ARTICLES
EGF- and CPA-induced mitogenic stimuli are differentially down- regulated by TGF-beta1 in cultured rat hepatocytes
Swiss Federal Institute of Technology and University of Zurich.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
P. Kasper and L. Mueller Sex-specific induction of apoptosis by cyproterone acetate in primary rat hepatocytes Carcinogenesis, November 1, 1999; 20(11): 2185 - 2188. [Abstract] [Full Text] [PDF] |
||||
